Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

NCP. Cross, T. Ernst, S. Branford, JM. Cayuela, M. Deininger, A. Fabarius, DDH. Kim, K. Machova Polakova, JP. Radich, R. Hehlmann, A. Hochhaus, JF. Apperley, S. Soverini

. 2023 ; 37 (11) : 2150-2167. [pub] 20231004

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000820

From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients. Our recommendations focus on current best practice and highlight the strengths and pitfalls of commonly used laboratory tests.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000820
003      
CZ-PrNML
005      
20240213093406.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41375-023-02048-y $2 doi
035    __
$a (PubMed)37794101
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Cross, Nicholas C P $u Faculty of Medicine, University of Southampton, Southampton, UK. ncpc@soton.ac.uk $1 https://orcid.org/0000000154812555
245    10
$a European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia / $c NCP. Cross, T. Ernst, S. Branford, JM. Cayuela, M. Deininger, A. Fabarius, DDH. Kim, K. Machova Polakova, JP. Radich, R. Hehlmann, A. Hochhaus, JF. Apperley, S. Soverini
520    9_
$a From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to critically consider the current status of genetic laboratory approaches to help diagnose and manage CML patients. Our recommendations focus on current best practice and highlight the strengths and pitfalls of commonly used laboratory tests.
650    _2
$a lidé $7 D006801
650    12
$a inhibitory proteinkinas $7 D047428
650    12
$a chronická myeloidní leukemie $x diagnóza $x genetika $x terapie $7 D015464
650    _2
$a recidiva $7 D012008
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Ernst, Thomas $u Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany $1 https://orcid.org/000000032147489X
700    1_
$a Branford, Susan $u Centre for Cancer Biology and SA Pathology, Adelaide, SA, Australia
700    1_
$a Cayuela, Jean-Michel $u Laboratory of Hematology, University Hospital Saint-Louis, AP-HP and EA3518, Université Paris Cité, Paris, France
700    1_
$a Deininger, Michael $u Huntsman Cancer Center Salt Lake City, Salt Lake City, UT, USA $1 https://orcid.org/0000000229871331
700    1_
$a Fabarius, Alice $u III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
700    1_
$a Kim, Dennis Dong Hwan $u Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada $1 https://orcid.org/0000000326404911
700    1_
$a Machova Polakova, Katerina $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000273985555 $7 xx0139783
700    1_
$a Radich, Jerald P $u Fred Hutchinson Cancer Center, Seattle, WA, USA $1 https://orcid.org/000000021618230X
700    1_
$a Hehlmann, Rüdiger $u III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany $u ELN Foundation, Weinheim, Germany
700    1_
$a Hochhaus, Andreas $u Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany $1 https://orcid.org/0000000306260834
700    1_
$a Apperley, Jane F $u Centre for Haematology, Imperial College London, London, UK $u Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK $1 https://orcid.org/0000000217101794
700    1_
$a Soverini, Simona $u Department of Medical and Surgical Sciences, Institute of Hematology "Lorenzo e Ariosto Seràgnoli", University of Bologna, Bologna, Italy $1 https://orcid.org/0000000245080353
773    0_
$w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 37, č. 11 (2023), s. 2150-2167
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37794101 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093403 $b ABA008
999    __
$a ok $b bmc $g 2049433 $s 1210514
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 37 $c 11 $d 2150-2167 $e 20231004 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace